Thalys(SH:603716) Zheng Xing Xing Ye Ri Bao·2025-09-15 08:42Market Overview - The pharmaceutical commercial sector experienced a slight decline of 0.14% on September 15, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3860.5, down 0.26%, while the Shenzhen Component Index rose by 0.63% to 13005.77 [1] Stock Performance - Notable gainers in the pharmaceutical sector included Baiyang Pharmaceutical, which rose by 1.37% to a closing price of 31.06, and HeFu China, which increased by 1.04% to 6.80 [1] - Saily Medical saw a significant decline of 3.96%, closing at 30.07, with a trading volume of 423,500 shares and a transaction value of 1.287 billion [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 338 million from major funds, while retail investors contributed a net inflow of 265 million [2][3] - The stock with the highest net inflow from major funds was Yifeng Pharmacy, with 25.68 million, while it faced a net outflow of 21.63 million from retail investors [3]